Noven Pharmaceuticals Recalls Minivelle Estradiol Patches Due to Temperature Abuse
Noven Pharmaceuticals is recalling Minivelle (estradiol) transdermal patches because prolonged exposure to temperatures outside labeled storage conditions may affect product quality.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a quality control issue (temperature abuse) without reported illnesses or injuries, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Noven Pharmaceuticals, Inc. is recalling 720 Minivelle (estradiol) transdermal patches, 0.05 mg/day, 8-count boxes. The specific lot affected is #76476 with an expiration date of 07/16. The product is distributed nationwide.
The recall was initiated due to temperature abuse, defined as prolonged exposure to temperatures outside of the labeled storage conditions. This condition may compromise the integrity of the transdermal system.
Consumers and healthcare providers with this specific lot should stop using the product and contact their pharmacist or Noven Pharmaceuticals for instructions on return or replacement.
The recalled product
- Product
- MINIVELLE (ESTRADIOL)
- Brand
- MINIVELLE
- Manufacturer
- Noven Pharmaceuticals, Inc.
- Category
- Drug — Transdermal Patch
- Affected units
- 720
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 76476
- Exp 07/16
UPCs (1)
- 0368968665083
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MINIVELLE
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defects
FDA (Drugs) · 2021-04-28
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defects
FDA (Drugs) · 2018-10-03
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
- SevereNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
Same manufacturer · Noven Pharmaceuticals, Inc.
See all →- HighPrescription Dextroamphetamine Patches Recalled for Defective Adhesive System
FDA (Drugs) · 2024-11-27
- HighDaytrana methylphenidate patches recalled for defective delivery system
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- ModerateDaytrana Methylphenidate Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Patches Recalled for Defective Transdermal Delivery System
FDA (Drugs) · 2023-03-29
Same hazard · temperature abuse
See all →- SevereKayem Foods Recalls Ready-to-Eat Meat and Poultry Due to Temperature Abuse
USDA FSIS · 2026-10-17
- ModerateZoladex Goserelin Implant Recalled Due to Temperature Abuse
FDA (Drugs) · 2026-10-07
- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
Similar recalls
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defects
FDA (Drugs) · 2021-04-28
- ModerateNoven Pharmaceuticals Recalls Minivelle Estradiol Transdermal Patches for Adhesive Defects
FDA (Drugs) · 2018-05-16
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-05-16
- LowNoven Recalls Minivelle Estradiol Patches Due to Defective Delivery System
FDA (Drugs) · 2017-07-05
- ModerateNoven Recalls Estradiol Transdermal Patches Due to Adhesive Defects
FDA (Drugs) · 2021-04-28
- ModerateCombipatch Transdermal System Recalled for Failed Stability Specifications
FDA (Drugs) · 2021-08-25